University of Innsbruck

NewHydrogen CEO Steve Hill Interviews Hydrogen Visionary Johannes Schwank

Retrieved on: 
Wednesday, October 11, 2023
Food, Congress, Chemical engineering, MDP, Ammonia, Chulalongkorn University, University, Carbon, Interim, Doctor of Philosophy, University of Innsbruck, Creativity, Google Scholar, Physical chemistry, Optimism, Hydrogen, James, Water, Oil, Chemical substance

SANTA CLARITA, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTCMKTS:NEWH), the developer of a breakthrough technology that uses clean energy and water to produce the world’s cheapest green hydrogen, today announced that in a recent podcast, the Company’s CEO, Steve Hill, spoke with Dr. Johannes Schwank, an eminent authority in physical chemistry and chemical engineering at the University of Michigan, about the future of hydrogen as an energy carrier.

Key Points: 
  • Reflecting on progress since his Congressional testimony in 2003, he noted, “The world is recognizing that we need to get our arms around hydrogen as an energy carrier.
  • And, if I’m not mistaken, just in the last few years, about 20 different countries have finally caught on and developed a national hydrogen strategy.”
    After discussing the recent surge of interest in hydrogen, Dr. Schwank said, “I am extremely optimistic ...
  • Schwank’s inspiring vision reaffirms that the green hydrogen revolution is not just inevitable; it’s a transformative force propelling us towards a sustainable future.”
    Dr. Johannes Schwank holds a Ph.D. in Physical Chemistry from Innsbruck University in Austria.
  • Dr. Schwank is listed as a Google Scholar at https://scholar.google.com/citations?user=azs-5XkAAAAJ&hl=en
    Watch the full discussion on the NewHydrogen Podcast featuring Dr. Johannes Schwank at https://newhydrogen.com/single-video.php?id=ywfKFPCIdHk .

Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors

Retrieved on: 
Tuesday, June 6, 2023
Biotechnology, Neurology, Diabetes, Health, Pharmaceutical, GSK plc, Obesity, University, Therapy, Allianz, International Center, LetterOne, DSM-IV codes, Multimedia, Franz Humer, International Centre for Missing & Exploited Children, University of Innsbruck, Temasek, Gastrointestinal disease, INSEAD, Drug discovery, Diageo, Pharmaceutical industry, Management

View the full release here: https://www.businesswire.com/news/home/20230606005244/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230606005244/en/
    Dr. Humer brings decades of managerial experience to the Kallyope board.
  • He has served as chair of several international companies and currently serves as:
    Member of the board of directors, Allogene Therapeutics
    Member of the board of directors, Emil Frey Holdings
    Member of the board of directors, LetterOne
    “Dr.
  • It is an honor to welcome him to Kallyope as chair of our board of directors,” said Jay Galeota, president and CEO, Kallyope.
  • “I am privileged to join the Kallyope board of directors as chair at this exciting time for the company,” said Dr. Humer.

TAWANI Foundation Gifts Over $1.3M to the SETI Institute and the Field Museum in Honor of Earth Day

Retrieved on: 
Thursday, April 20, 2023
Field Museum of Natural History, Swiss, Swiss Federal Institute of Technology, Vrije Universiteit Brussel, Solar System, University, Prevalence, Life, SETI Institute, Exploration, Face, Ames Research Center, Geological Survey of India, Intelligence, Research, Pritzker family, History, Entomology, University of Innsbruck, SETI, Geology, Planet, RET, Knowledge, Cosmic dust, Environment, Swiss Federal Institute of Aquatic Science and Technology, Pharmaceutical industry, Rare-earth element, Silicon, Meteoritics

Chicago, April 20, 2023 (GLOBE NEWSWIRE) -- The TAWANI Foundation announces its commitment of $1.3M to the SETI Institute and continued support for the Robert A. Pritzker Center for Meteoritics and Polar Studies at the Field Museum in honor of Earth Day.

Key Points: 
  • Chicago, April 20, 2023 (GLOBE NEWSWIRE) -- The TAWANI Foundation announces its commitment of $1.3M to the SETI Institute and continued support for the Robert A. Pritzker Center for Meteoritics and Polar Studies at the Field Museum in honor of Earth Day.
  • This year, the Institute’s Anthropo Snow Project will receive $210,000, the first installment of a three-year gift totaling $630,000.
  • Heck serves as curator of Meteoritics and Polar Studies and senior director of research at the Field Museum.
  • “We are proud to support these and other paleoenvironmental studies this Earth Day and beyond.”
    To learn more about TAWANI Foundation grants, visit www.tawanifoundation.org/our-grants .

Alltrna Appoints Caroline Kӧhrer, Ph.D., Vice President, Discovery Platform

Retrieved on: 
Monday, October 17, 2022
Rubius, Infection, Ribosome, Microbiology, Disease, Therapy, Content discovery platform, Technology, RNA transfection, Growth, Essential amino acid, SANA, NASDAQ, Biology, RNA, Research, Publication, University of Innsbruck, PNAS, Multimedia, Science, Investment, Flagship Pioneering, Protein engineering, University, MRNA, Health, CEO, Ecosystem, Flagship, Cell Metabolism, Springer, David Berry (inventor), Nature Communications, Massachusetts Institute of Technology, Autoimmunity, COVID-19, Language, Leadership, Vaccine, Pharmaceutical industry, Medical device, Fine chemical, Moderna

CAMBRIDGE, Mass., Oct. 17, 2022 /PRNewswire/ -- Alltrna, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of Caroline Kӧhrer, Ph.D., as Vice President, Discovery Platform. 

Key Points: 
  • Under her leadership, Moderna expanded the mechanistic understanding of mRNA design principles underlying current and future mRNA therapeutics, including Moderna's Spikevax mRNA vaccine for COVID-19.
  • "We are excited to have Caroline join us as we boldly establish a first-in-field platform to advance tRNA as a new modality with exceptional and unique therapeutic potential."
  • The company's platform incorporates AI/ML tools to learn the tRNA language and deliver diverse programmable molecules with broad therapeutic potential.
  • Alltrna has an unprecedented opportunity to advance a single tRNA medicine to unify treatment across a wide range of diseases with the same underlying genetic mutation.

AIP Publishing Signs Three-Year Read & Publish Agreement with the University of Innsbruck

Retrieved on: 
Friday, February 4, 2022
View, Review of Scientific Instruments, Chemical physics, Journal of Vacuum Science and Technology, University of Sydney School of Molecular Bioscience, University, Journal of the Acoustical Society of America, Communication, Politics, Alpine Space Programme, Review, Research, Publishing, AIP, The Journal of Chemical Physics, University of Innsbruck, Journal, American Institute, American Institute of Physics, Institute of Research and Technology b-com, American Vacuum Society, Cultural conflict, Open access, Multimedia, Scientific instrument, Physics

MELVILLE, N.Y., Feb. 4, 2022 /PRNewswire/ -- AIP Publishing , a leading not-for-profit scholarly publisher in the physical sciences, has signed a Read and Publish agreement with the University of Innsbruck , Austria.

Key Points: 
  • MELVILLE, N.Y., Feb. 4, 2022 /PRNewswire/ -- AIP Publishing , a leading not-for-profit scholarly publisher in the physical sciences, has signed a Read and Publish agreement with the University of Innsbruck , Austria.
  • They also benefit from read access to most of the titles from AIP Publishing and its publishing partners.
  • "We are excited to be able to offer our researchers new opportunities through our agreement with AIP Publishing," said Erika Prnbacher.
  • "We are so pleased to offer researchers at the University of Innsbruck an opportunity to publish open access in these leading journals."

New, Unpublished Data Reveals Impact of COVID-19 in Patients With Neurological Disorders; Renowned Neuroscientist Ettore Beghi Presents Findings in "Special Lecture on Neuro COVID," Oct 4, 2021, World Congress of Neurology 2021

Retrieved on: 
Tuesday, October 5, 2021
Guillain–Barré syndrome, Neurological disorder, Neurodegeneration, World Federation of Neurology, Congress, European Academy of Neurology, Even and odd functions, World government, Stroke, Hospital, National, Dysexecutive syndrome, Patient, Peripheral neuropathy, University of Bern, University of Milan, Hypertension, Twitter, WCN, COVID, Death, University, Cardiovascular disease, Government budget balance, University of Innsbruck, Risk, Society, COVID-19, Grenoble Alpes University, Peripheral nervous system, SIN, Research, Association, Data, WFN, Brain, History, Organization, Time, United Kingdom, Registry, Lists of diseases, Pharmaceutical industry

Beghi's presentation, "Special Lecture on Neuro COVID," detailed both published and newly released findings of the European Academy of Neurology COVID-19 Registry (ENERGY), of which Beghi is a member.

Key Points: 
  • Beghi's presentation, "Special Lecture on Neuro COVID," detailed both published and newly released findings of the European Academy of Neurology COVID-19 Registry (ENERGY), of which Beghi is a member.
  • "COVID-19 worsens patients' functional abilities, putting them at a greater risk of premature mortality, prolonged hospitalization and persistingneurological symptoms during follow-up," he added.
  • Data also reveals that patients with neurodegenerative diseases tend to have more severe COVID cases and worse outcomes than those who do not.
  • With support from member organizations around the globe, WFN unites the world to allow patients greater access to brain health.

New, Unpublished Data Reveals Impact of COVID-19 in Patients With Neurological Disorders; Renowned Neuroscientist Ettore Beghi Presents Findings in "Special Lecture on Neuro COVID," Oct 4, 2021, World Congress of Neurology 2021

Retrieved on: 
Tuesday, October 5, 2021
Guillain–Barré syndrome, Neurological disorder, Neurodegeneration, World Federation of Neurology, Congress, European Academy of Neurology, Even and odd functions, World government, Stroke, Hospital, National, Dysexecutive syndrome, Patient, Peripheral neuropathy, University of Bern, University of Milan, Hypertension, Twitter, WCN, COVID, Death, University, Cardiovascular disease, Government budget balance, University of Innsbruck, Risk, Society, COVID-19, Grenoble Alpes University, Peripheral nervous system, SIN, Research, Association, Data, WFN, Brain, History, Organization, Time, United Kingdom, Registry, Lists of diseases, Pharmaceutical industry

Beghi's presentation, "Special Lecture on Neuro COVID," detailed both published and newly released findings of the European Academy of Neurology COVID-19 Registry (ENERGY), of which Beghi is a member.

Key Points: 
  • Beghi's presentation, "Special Lecture on Neuro COVID," detailed both published and newly released findings of the European Academy of Neurology COVID-19 Registry (ENERGY), of which Beghi is a member.
  • "COVID-19 worsens patients' functional abilities, putting them at a greater risk of premature mortality, prolonged hospitalization and persistingneurological symptoms during follow-up," he added.
  • Data also reveals that patients with neurodegenerative diseases tend to have more severe COVID cases and worse outcomes than those who do not.
  • With support from member organizations around the globe, WFN unites the world to allow patients greater access to brain health.

Mercury Systems announces appointment of Thomas Huber as Executive Vice President, Chief Transformation Officer

Retrieved on: 
Tuesday, September 7, 2021

ANDOVER, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Mercury Systems, Inc., (NASDAQ: MRCY, www.mrcy.com ), a leader in trusted, secure mission-critical technologies for aerospace and defense, today announced that Thomas Huber has joined the Company as executive vice president and chief transformation officer, effective Sept. 7, 2021.

Key Points: 
  • ANDOVER, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Mercury Systems, Inc., (NASDAQ: MRCY, www.mrcy.com ), a leader in trusted, secure mission-critical technologies for aerospace and defense, today announced that Thomas Huber has joined the Company as executive vice president and chief transformation officer, effective Sept. 7, 2021.
  • Reporting to Mark Aslett, Mercurys president and chief executive officer, Mr. Huber will lead the Companys 1MPACT strategic value creation initiative announced in its fourth-quarter fiscal 2021 earnings release.
  • He is a proven senior executive with extensive experience in driving enterprise value for Fortune 500 companies.
  • I look forward to working with the leadership team and all my new Mercury colleagues to deliver successful transformation outcomes.